Answers are grounded in this paper and cite their sources.
Review highlights advancements in adult multipotent stromal cell technology for bone healing, indicating ongoing challenges for clinical use.
Since the discovery of bone marrow derived stromal cell osteogenesis in the 1960s, tissue engineering with adult multipotent stromal cells (MSCs) has evolved as a promising approach to restore structure and function of bone compromised by injury or disease. To date, accelerated bone formation with MSCs has been demonstrated with a variety of tissue engineering strategies. Though MSC bone tissue engineering has advanced over the last few decades, limitations to clinical translation remain. A current review of this promising field is presented with a specific focus on equine investigations.
No takes yet. Share an insight, caveat, or question.
Lopez et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: